Deborah J. Wexler
Harvard University1 paperORCID 0000-0001-6979-402XOpenAlex
Papers
Clinical Journal of the American Society of NephrologyHumans
SGLT2 inhibitors match GLP-1 drugs for overall kidney outcomes
In older veterans, primary kidney and survival risks matched with a hazard ratio of 1.00, though SGLT2 inhibitors showed lower sustained kidney…In older veterans, primary kidney and survival risks matched with a hazard ratio of 1.00, though SGLT2 inhibitors showed lower sustained kidney decline and end-stage disease.